Relationship of a Claims-Based Frailty Index to Annualized Medicare Costs: A Cohort Study
- PMID: 32252070
- DOI: 10.7326/M19-3261
Relationship of a Claims-Based Frailty Index to Annualized Medicare Costs: A Cohort Study
Abstract
Background: Medicare uses the Centers for Medicare & Medicaid Services Hierarchical Condition Category (CMS-HCC) model to predict patients' annualized Medicare costs in value-based payment programs. The CMS-HCC model does not include measures of frailty, and prior research shows that it systematically underpredicts costs for frail Medicare beneficiaries.
Objective: To determine whether a claims-based frailty index can improve Medicare cost prediction.
Design: Retrospective cohort study.
Setting: Medicare Current Beneficiary Survey linked to Medicare claims, 2006 to 2013.
Participants: 16 535 community-dwelling, fee-for-service beneficiaries representing 26 705 patient-years.
Measurements: Patient frailty status was classified using a validated claims-based frailty index. The association between the frailty index and annualized Medicare costs was examined, and regression methods were used to compare observed Medicare costs versus predictions based on the standard CMS-HCC model with and without the frailty index.
Results: Mean costs were $5724 for the 8910 patients classified as robust (46.4% of patient-years), $12 462 for the 8405 prefrail patients (41.6%), $26 239 for the 2215 mildly frail patients (9.6%), and $44 586 for the 593 patients classified as moderately to severely frail (2.5%). The frailty index addition to the CMS-HCC model predicted on average an additional $2712, $7915, and $16 449 in costs for prefrail, mildly frail, and moderately to severely frail patients, respectively, beyond the CMS-HCC model alone. On average, the model with the frailty index addition resulted in more accurate predictions of costs for patients at all 4 levels of frailty. However, observed costs remained more widely distributed than predictions from the enhanced model at all levels of frailty.
Limitation: The claims-based index is a proxy for frailty and is likely less accurate than an in-person examination.
Conclusion: The CMS-HCC model with the frailty index addition is an improvement over current Medicare cost prediction.
Primary funding source: None.
Comment in
-
Frailty, Equity, and Medicare Costs.Ann Intern Med. 2020 Apr 21;172(8):562-563. doi: 10.7326/M20-0873. Epub 2020 Apr 7. Ann Intern Med. 2020. PMID: 32252066 No abstract available.
Similar articles
-
Incremental Health Care Costs of Self-Reported Functional Impairments and Phenotypic Frailty in Community-Dwelling Older Adults : A Prospective Cohort Study.Ann Intern Med. 2023 Apr;176(4):463-471. doi: 10.7326/M22-2626. Epub 2023 Apr 4. Ann Intern Med. 2023. PMID: 37011386 Free PMC article.
-
Relationship between Claims-Based Frailty Index and Eye Care Utilization among Medicare Beneficiaries with Glaucoma.Ophthalmology. 2023 Jun;130(6):646-654. doi: 10.1016/j.ophtha.2023.01.015. Epub 2023 Jan 31. Ophthalmology. 2023. PMID: 36731798 Free PMC article.
-
Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study.J Gerontol A Biol Sci Med Sci. 2019 Jul 12;74(8):1271-1276. doi: 10.1093/gerona/gly197. J Gerontol A Biol Sci Med Sci. 2019. PMID: 30165612 Free PMC article.
-
Frailty Phenotype and Healthcare Costs and Utilization in Older Men.J Am Geriatr Soc. 2020 Sep;68(9):2034-2042. doi: 10.1111/jgs.16522. Epub 2020 May 13. J Am Geriatr Soc. 2020. PMID: 32402097 Free PMC article.
-
Change in a Claims-Based Frailty Index, Mortality, and Health Care Costs in Medicare Beneficiaries.J Gerontol A Biol Sci Med Sci. 2023 Jul 8;78(7):1198-1203. doi: 10.1093/gerona/glad010. J Gerontol A Biol Sci Med Sci. 2023. PMID: 36630699 Free PMC article.
Cited by
-
Unleashing frailty from laboratory into real world: A critical step toward frailty-guided clinical care of older adults.J Am Geriatr Soc. 2024 Nov;72(11):3299-3314. doi: 10.1111/jgs.19151. Epub 2024 Aug 21. J Am Geriatr Soc. 2024. PMID: 39166879
-
Home Health Care Use and Outcomes After Coronary Artery Bypass Grafting Among Medicare Beneficiaries.Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010459. doi: 10.1161/CIRCOUTCOMES.123.010459. Epub 2024 May 21. Circ Cardiovasc Qual Outcomes. 2024. PMID: 38770653
-
Association of Frailty with Healthcare Utilization for Patients over One Year Following Surgical Evaluation.Ann Surg. 2024 Jan 24:10.1097/SLA.0000000000006218. doi: 10.1097/SLA.0000000000006218. Online ahead of print. Ann Surg. 2024. PMID: 38264904
-
Association of Insurance Type with Inpatient Surgical 30-day Readmissions, Emergency Department Visits/Observation Stays, and Costs.Ann Surg Open. 2023 Mar;4(1):e235. doi: 10.1097/as9.0000000000000235. Epub 2023 Feb 14. Ann Surg Open. 2023. PMID: 37588413 Free PMC article.
-
Drivers of Individual and Regional Variation in CMS Hierarchical Condition Categories Among Florida Beneficiaries.Risk Manag Healthc Policy. 2023 Jun 10;16:1011-1022. doi: 10.2147/RMHP.S401474. eCollection 2023. Risk Manag Healthc Policy. 2023. PMID: 37323190 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical